Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1Hepatitis C 1Fibrosis 1Diabetes Mellitus 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Social Determinants of Health 2Electrocardiography 2Echocardiography 2zanubrutinib 1sofosbuvir-velpatasvir drug combination 1ribociclib 1palbociclib 1acalabrutinib 1abemaciclib 1Vascular Stiffness 1Standard of Care 1Restraint, Physical 1Referral and Consultation 1Quality of Life 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutrition Assessment 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1High-Intensity Interval Training 1Hematologic Tests 1Health Information Exchange 1Geritol 1Fish Oils 1Fatty Acids, Omega-3 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × sofosbuvir-velpatasvir drug combination × 1 year × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡